Revolutionizing Neurology Payer Portal Automation for Complex Therapies

The Challenge of Neurology Prior Authorizations

Neurology prior authorizations are uniquely complex, driven by high-cost disease-modifying therapies (DMTs) for conditions like Multiple Sclerosis (MS), CGRP migraine biologics, and novel Alzheimer's treatments. These often require extensive documentation, adherence to AAN Practice Guidelines, and frequent re-authorizations, creating a substantial administrative burden for revenue cycle teams.

High-Volume PA Triggers in Neurology

• MS Disease-Modifying Therapies (DMTs) such as ocrelizumab, natalizumab, and oral DMTs, often requiring step therapy compliance.
• CGRP Monoclonal Antibodies for migraine prevention (e.g., erenumab, fremanezumab) and oral gepants.
• Alzheimer's Anti-Amyloid Antibodies (lecanemab, donanemab), demanding amyloid confirmation and specific MRI screening.
• Advanced Imaging like brain MRI, MR angiography, and amyloid PET scans.
• Botox for chronic migraine, spasticity, and dystonia, with specific indication and prior therapy requirements.
• Neuromodulation procedures including Deep Brain Stimulation (DBS) and Vagus Nerve Stimulation (VNS).

Bridging the Payer Portal Gap for Neurology

Despite the critical nature of neurology PAs, many payers lack robust API capabilities for electronic submission, forcing reliance on manual portal interactions. This 'current-state workflow' involves individual logins, navigating varied portal UIs, and manual data transcription from EMRs, exacerbating the time-sensitive nature of many neurology treatments.

Klivira's Automated Payer Portal Workflow for Neurology PAs

• **Headless Browser Automation**: Klivira operates automated sessions against non-API payer portals, handling login, navigation, form filling, and submission for neurology-specific PA requests.
• **Per-Payer Adapters**: Our platform maintains unique adapters for each payer portal, understanding their specific forms, fields, and multi-step submission flows relevant to neurology treatments.
• **EMR Data Integration**: Patient demographics and clinical context, including McDonald criteria for MS or migraine diaries, are automatically transcribed from your EMR to the payer portal.
• **Automated Attachment Upload**: Clinical documentation, such as MRI findings, EDSS scores, or neuropsychological evaluations, are automatically uploaded as required by payers.
• **Continuous Status Monitoring**: Automated polling of payer portals eliminates manual status checks, providing real-time updates on neurology PA approvals or denials.
• **CMS-0057-F Transition**: Klivira's architecture is designed to transition from portal automation to API-based PA (e.g., Da Vinci PAS, X12 278) as payers comply with future mandates.

Addressing Common Neurology PA Denial Reasons

Klivira's automation, informed by AAN guidelines, helps mitigate common denial reasons in neurology. This includes tracking step therapy compliance for MS DMTs and CGRP migraine prevention, and ensuring complete documentation for Alzheimer's anti-amyloid antibodies, such as amyloid biomarker confirmation.

Operational Impact for Neurology Practices

By automating neurology payer portal workflows, Klivira significantly reduces the time-per-PA, minimizes transcription errors, and alleviates coordinator burnout. This allows your team to focus on complex cases and patient care, rather than repetitive manual data entry across disparate payer systems.